[177Lu]Lu-PentixaTher

pentixafor labeled with lutetium-177

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [177Lu]Lu-PentixaTher, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia. [Phase 1, Phase 2]